Skip to main content
SpringerLink
Log in

Intensive Insulintherapie und Volumentherapie mit 10%iger Hemohes® zur Behandlung von Patienten mit schwerer Sepsis

Die VISEP-Studie

Intensive insulin therapy and volume substitution with 10% Hemohes® for treatment of patients with severe sepsis

The VISEP trial

  • Literatur im Fokus
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Berghe G van den, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359–1367

    Article  PubMed  Google Scholar 

  2. Gale SC, Sicoutris C, Reilly PM et al. (2007) Poor glycemic control is associated with increased mortality in critically ill trauma patients. Am Surg 73: 454–460

    PubMed  Google Scholar 

  3. Lang K, Suttner S, Boldt J et al. (2003) Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anaesth 50: 1009–1016

    Article  PubMed  Google Scholar 

  4. Treggiari MM, Karir V, Yanez ND et al. (2008) Intensive insulin therapy and mortality in critically ill patients. Crit Care 12: R29; Epub 2008, Feb 29

    Article  PubMed  Google Scholar 

  5. Schortgen F, Lacherade JC, Bruneel F et al. (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357: 911–916

    Article  PubMed  CAS  Google Scholar 

  6. Blasco V, Leone M, Antonini F et al. (2008) Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 100: 504–508

    Article  PubMed  CAS  Google Scholar 

  7. Ospina-Tascón GA, Büchele GL, Vincent JL (2008) Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med 36: 1311–1322

    PubMed  Google Scholar 

  8. Vincent JL, Fink MP, Marini JJ et al. (2006) Intensive care and emergency medicine: progress over the past 25 years. Chest 129: 1061–1067

    Article  PubMed  Google Scholar 

  9. Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Kein Autor hat einen Interessenskonflikt in Bezug auf Medikamente oder Methoden, die in diesem Manuskript diskutiert werden.

Author information

Authors and Affiliations

  1. Abteilung für Anästhesie und Intensivmedizin, Krankenhaus der Barmherzigen Schwestern, 4910, Ried im Innkreis, Österreich

    W.R. Hasibeder

  2. Klinik für Anästhesie und Intensivmedizin, Medizinische Universität Innsbruck, Innsbruck, Österreich

    M.W. Dünser

Authors
  1. W.R. Hasibeder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M.W. Dünser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W.R. Hasibeder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasibeder, W., Dünser, M. Intensive Insulintherapie und Volumentherapie mit 10%iger Hemohes® zur Behandlung von Patienten mit schwerer Sepsis. Anaesthesist 57, 720–722 (2008). https://doi.org/10.1007/s00101-008-1390-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-008-1390-2

Search

Navigation